These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25589881)

  • 1. BSL-3 Laboratory User Training Program at NUITM-KEMRI.
    Bundi M; Miring'u G; Inoue S; Muriithi B; Ashur S; Wandera E; Kathiiko C; Odoyo E; Narita C; Kwalla A; Galata A; Makumi A; Huka S; Shah M; Karama M; Shimada M; Bii C; Kariuki S; Horio M; Ichinose Y
    Trop Med Health; 2014 Dec; 42(4):171-6. PubMed ID: 25589881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosafety and biosecurity capacity building: insights from implementation of the NUITM-KEMRI biosafety training model.
    Muriithi B; Bundi M; Galata A; Miringu G; Wandera E; Kathiiko C; Odoyo E; Kamemba M; Amukoye E; Huqa S; Shah M; Inoue S; Ichinose Y
    Trop Med Health; 2018; 46():30. PubMed ID: 30116141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Networking for training Level 3/4 biosafety laboratory staff.
    Huang Y; Huang J; Xia H; Shi Y; Ma H; Yuan Z
    J Biosaf Biosecur; 2019 Mar; 1(1):46-49. PubMed ID: 32501432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.
    Homer LC; Alderman TS; Blair HA; Brocard AS; Broussard EE; Ellis RP; Frerotte J; Low EW; McCarthy TR; McCormick JM; Newton JM; Rogers FC; Schlimgen R; Stabenow JM; Stedman D; Warfield C; Ntiforo CA; Whetstone CT; Zimmerman D; Barkley E
    Biosecur Bioterror; 2013 Mar; 11(1):10-9. PubMed ID: 23477631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosafety Training and Incident-reporting Practices in the United States: A 2008 Survey of Biosafety Professionals.
    Chamberlain AT; Burnett LC; King JP; Whitney ES; Kaufman SG; Berkelman RL
    Appl Biosaf; 2009; 14(3):135-143. PubMed ID: 20890389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosafety Level 4 Laboratory User Training Program, China.
    Xia H; Huang Y; Ma H; Liu B; Xie W; Song D; Yuan Z
    Emerg Infect Dis; 2019 May; 25(5):. PubMed ID: 31002302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices.
    Mazur S; Holbrook MR; Burdette T; Joselyn N; Barr J; Pusl D; Bollinger L; Coe L; Jahrling PB; Lackemeyer MG; Wada J; Kuhn JH; Janosko K
    J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.
    Janosko K; Holbrook MR; Adams R; Barr J; Bollinger L; Newton JT; Ntiforo C; Coe L; Wada J; Pusl D; Jahrling PB; Kuhn JH; Lackemeyer MG
    J Vis Exp; 2016 Oct; (116):. PubMed ID: 27768063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biosafety of microbiological laboratories in Korea].
    Lee JY; Eun SJ; Park KD; Kim JK; Im JS; Hwang YS; Kim YI
    J Prev Med Public Health; 2005 Nov; 38(4):449-56. PubMed ID: 16358832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NUITM-KEMRI P3 Laboratory in Kenya: Establishment, Features, Operation and Maintenance.
    Inoue S; Wandera E; Miringu G; Bundi M; Narita C; Ashur S; Kwallah A; Galata A; Abubakar M; Suka S; Mohamed S; Karama M; Horio M; Shimada M; Ichinose Y
    Trop Med Health; 2013 Mar; 41(1):27-37. PubMed ID: 23533023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage.
    ; Gangadharan D; Smith J; Weyant R
    MMWR Recomm Rep; 2013 Jun; 62(RR-06):1-7. PubMed ID: 23803973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good laboratory practices guarantee biosafety in the Sierra Leone-China friendship biosafety laboratory.
    Wang Q; Zhou WM; Zhang Y; Wang HY; Du HJ; Nie K; Song JD; Xiao K; Lei WW; Guo JQ; Wei HJ; Cai K; Wang YH; Wu J; Kamara G; Kamara I; Wei Q; Liang MF; Wu GZ; Dong XP
    Infect Dis Poverty; 2016 Jun; 5(1):62. PubMed ID: 27333890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framework for leadership and training of Biosafety Level 4 laboratory workers.
    Le Duc JW; Anderson K; Bloom ME; Estep JE; Feldmann H; Geisbert JB; Geisbert TW; Hensley L; Holbrook M; Jahrling PB; Ksiazek TG; Korch G; Patterson J; Skvorak JP; Weingartl H
    Emerg Infect Dis; 2008 Nov; 14(11):1685-8. PubMed ID: 18976549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmonization of Biosafety and Biosecurity Standards for High-Containment Facilities in Low- and Middle-Income Countries: An Approach From the Perspective of Occupational Safety and Health.
    Maehira Y; Spencer RC
    Front Public Health; 2019; 7():249. PubMed ID: 31572701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining differential pressure gradients does not increase safety inside modern BSL-4 laboratories.
    Kurth A; Weber U; Reichenbacher D
    Front Bioeng Biotechnol; 2022; 10():953675. PubMed ID: 36110311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of High-Containment Biological Laboratories Performing Work During the COVID-19 Pandemic: Biosafety Level-3 and -4 Labs.
    Yeh KB; Tabynov K; Parekh FK; Mombo I; Parker K; Tabynov K; Bradrick SS; Tseng AS; Yang JR; Gardiner L; Olinger G; Setser B
    Front Bioeng Biotechnol; 2021; 9():720315. PubMed ID: 34485259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus-Based Surrogate Systems for BSL-2 High-Throughput Screening of Antivirals Targeting BSL-3/4 Hemorrhagic Fever-Causing Viruses.
    Radoshitzky SR; Soloveva V; Gharaibeh D; Kuhn JH; Bavari S
    Methods Mol Biol; 2018; 1604():393-403. PubMed ID: 28986850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of risk perception on biosafety level-2 laboratory workers' hand-to-face contact behaviors.
    Johnston JD; Eggett D; Johnson MJ; Reading JC
    J Occup Environ Hyg; 2014; 11(9):625-32. PubMed ID: 24479417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safeguards for Using Viral Vector Systems in Human Gene Therapy: A Resource for Biosafety Professionals Mitigating Risks in Health Care Settings.
    Brown AM; Blind J; Campbell K; Ghosh S
    Appl Biosaf; 2020 Dec; 25(4):184-193. PubMed ID: 36032394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management System Approach for Addressing Biosafety and Biosecurity of Emerging Pathogens in a Biosafety Level-3 Core Facility.
    Joseph T
    Appl Biosaf; 2021 Dec; 26(4):210-220. PubMed ID: 36034099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.